THE UNANSWERED QUESTIONS.

Authors: Lawton, Graham (AUTHOR)

Source: New Scientist. 1/4/2025 Special Issue, Vol. 265 Issue 3524, p16-18. 3p. 5 Color Photographs.

Subjects: SARS-CoV-2 Omicron variant, SARS-CoV-2 Delta variant, LABORATORY accidents, ENDEMIC diseases, COVID-19 pandemic, WHITE-tailed deer

Implementing SARS-CoV-2 routine surveillance in antenatal care in Zambia, 2021–2022: best practices and lessons learned.

Authors: Tembo, Tannia¹ (AUTHOR) Taniya.Tembo@cidrz.org, Heilmann, Elizabeth^2,3 (AUTHOR), Kabamba, Bupe Mulenga⁴ (AUTHOR), Fwoloshi, Sombo⁵ (AUTHOR), Kalenga, Kalubi¹ (AUTHOR), Chilambe, Felix⁵ (AUTHOR), Siwinga, Mpanji⁵ (AUTHOR), Rutagwera, Marie-Reine⁴ (AUTHOR), Musunse, Maximillian⁴ (AUTHOR), Kangale, Chabu⁴ (AUTHOR), Yingst, Samuel³ (AUTHOR), Yadav, Ruchi⁶ (AUTHOR), Savory, Theodora¹ (AUTHOR), Gutman, Julie R.⁶ (AUTHOR), Sikazwe, Izukanji¹ (AUTHOR), Mulenga, Lloyd B.⁵ (AUTHOR), Moore, Carolyn Bolton^1,7 (AUTHOR), Hines, Jonas Z.³ (AUTHOR)

Source: BMC Public Health. 2/28/2025, Vol. 25 Issue 1, p1-10. 10p.

Subject Terms: *SARS-CoV-2 Delta variant, *HEALTH facilities, *MEDICAL care, *COVID-19, *MEDICAL sciences

Modeling-based design of adaptive control strategy for the effective preparation of 'Disease X'.

Authors: Wang, Hao¹ (AUTHOR), Zhou, Weike² (AUTHOR), Wang, Xia¹ (AUTHOR), Xiao, Yanni³ (AUTHOR), Tang, Sanyi⁴ (AUTHOR) sytang@sxu.edu.cn, Tang, Biao³ (AUTHOR) biaotang@xjtu.edu.cn

Source: BMC Medical Informatics & Decision Making. 2/19/2025, Vol. 25 Issue 1, p1-15. 15p.

Subject Terms: *SARS-CoV-2 Delta variant, *SARS-CoV-2 Omicron variant, *EMERGING infectious diseases, *ADAPTIVE control systems, *VACCINATION status

COVID-19 symptom severity and duration among outpatients, July 2021-May 2023: The PROTECT observational study.

Authors: Vashi, Bhavya¹ (AUTHOR), Pettrone, Kristen¹ (AUTHOR) KPettrone@aceso-sepsis.org, Wilson, Claire S.² (AUTHOR), Chenoweth, Josh G.¹ (AUTHOR), Brandsma, Joost¹ (AUTHOR), Gregory, Melissa K.¹ (AUTHOR), Genzor, Pavol¹ (AUTHOR), Striegel, Deborah A.¹ (AUTHOR), Rothman, Richard E.² (AUTHOR), Hansoti, Bhakti² (AUTHOR), Avornu, Gideon D.² (AUTHOR), McBryde, Breana² (AUTHOR), Zimmerman, Lauren Reynolds² (AUTHOR), Woods, Christopher W.³ (AUTHOR), Petzold, Elizabeth A.³ (AUTHOR), Cowden, Jessica⁴ (AUTHOR), Nitayaphan, Sorachai⁵ (AUTHOR), Nasomsong, Worapong⁶ (AUTHOR), Clark, Danielle V.¹ (AUTHOR)

Source: PLoS ONE. 2/21/2025, Vol. 20 Issue 2, p1-15. 15p.

Subject Terms: *SARS-CoV-2 Delta variant, *SARS-CoV-2 Omicron variant, *DISEASE risk factors, *SARS-CoV-2, *COVID-19, *PROPORTIONAL hazards models

9-aminominocycline potentiates the efficacy of EIDD-1931 and PF-332 by targeting the papain like protease enzyme of SARS-CoV-2.

Authors: Pandey, Kabita¹ (AUTHOR), Lewis, Devin Shane M.² (AUTHOR), Heo, Kyeongin² (AUTHOR), Acharya, Arpan¹ (AUTHOR), Fields, Travis² (AUTHOR), Gowda, Kritika^2,3 (AUTHOR), Dean, George² (AUTHOR), Rayalam, Srujana² (AUTHOR), Byrareddy, Siddappa N.¹ (AUTHOR) sid.byrareddy@unmc.edu, Mody, Vicky² (AUTHOR) vickymo@pcom.edu, Taval, Shashidharamurthy² (AUTHOR) rangaiahsh@pcom.edu

Source: Scientific Reports. 2/15/2025, Vol. 15 Issue 1, p1-13. 13p.

Subject Terms: *SARS-CoV-2 Omicron variant, *SARS-CoV-2 Delta variant, *RNA replicase, *COVID-19 treatment, *ENZYME kinetics

Transcriptomic profiles of monocyte-derived macrophages exposed to SARS-CoV-2 VOCs reveal immune-evasion escape driven by delta.

Authors: Gallo, Alessia¹ (AUTHOR) agallo@ismett.edu, Sammartino, Josè Camilla² (AUTHOR) j.sammartino@smatteo.pv.it, Vazzana, Roberta¹ (AUTHOR) rvazzana@ismett.edu, Giambruno, Roberto³ (AUTHOR) roberto.giambruno@irib.cnr.it, Carcione, Claudia⁴ (AUTHOR) ccarcione@fondazionerimed.com, Cuscino, Nicola¹ (AUTHOR) ncuscino@ismett.edu, Castelbuono, Salvatore¹ (AUTHOR) scastelbuono@ismett.edu, Miceli, Vitale¹ (AUTHOR) vmiceli@ismett.edu, Bulati, Matteo¹ (AUTHOR) mbulati@ismett.edu, Lilleri, Daniele⁵ (AUTHOR) d.lilleri@smatteo.pv.it, Cassaniti, Irene^2,5 (AUTHOR) i.cassaniti@smatteo.pv.it, Conaldi, Pier Giulio¹ (AUTHOR) pgconaldi@ismett.edu, Baldanti, Fausto^2,5 (AUTHOR) fausto.baldanti@unipv.it

Source: Journal of Translational Medicine. 2/4/2025, Vol. 23 Issue 1, p1-18. 18p.

Subject Terms: *SARS-CoV-2, *SARS-CoV-2 Delta variant, *SARS-CoV-2 Omicron variant, *LINCRNA, *NON-coding RNA

The R203M and D377Y mutations of the nucleocapsid protein promote SARS-CoV-2 infectivity by impairing RIG-I-mediated antiviral signaling.

Authors: Li, Yongkui^1,2,3 (AUTHOR), Li, Moran^2,3 (AUTHOR), Xiao, Heng^2,3 (AUTHOR), Liao, Feng⁴ (AUTHOR), Shen, Miaomiao⁵ (AUTHOR), Ge, Weiwei^2,3 (AUTHOR), Ou, Junxian^2,3 (AUTHOR), Liu, Yuqing^2,3 (AUTHOR), Chen, Lumiao⁶ (AUTHOR), Zhao, Yue^2,3 (AUTHOR), Wan, Pin^2,3 (AUTHOR), Liu, Jinbiao^2,3 (AUTHOR), Chen, Jun^2,3 (AUTHOR), Lan, Xianwu⁶ (AUTHOR), Wu, Shaorong⁶ (AUTHOR), Ding, Qiang⁷ (AUTHOR), Li, Geng⁴ (AUTHOR) lg@gzucm.edu.cn, Zhang, Qiwei^2,3 (AUTHOR) zhangqw@jnu.edu.cn, Pan, Pan^1,2,3,6 (AUTHOR) panpan@gzhmu.edu.cn

Source: PLoS Pathogens. 1/22/2025, Vol. 21 Issue 1, p1-28. 28p.

Subject Terms: *SARS-CoV-2 Delta variant, *SARS-CoV-2 Omicron variant, *VIRAL proteins, *SARS-CoV-2, *VIRAL mutation, *TYPE I interferons

Household transmission of SARS-CoV-2 in five US jurisdictions: Comparison of Delta and Omicron variants.

Authors: Baker, Julia M.^1,2 (AUTHOR) nwk0@cdc.gov, Nakayama, Jasmine Y.^1,2 (AUTHOR), O'Hegarty, Michelle¹ (AUTHOR), McGowan, Andrea^1,3 (AUTHOR), Teran, Richard A.^2,4 (AUTHOR), Bart, Stephen M.^2,5 (AUTHOR), Sosa, Lynn E.⁵ (AUTHOR), Brockmeyer, Jessica⁵ (AUTHOR), English, Kayla⁴ (AUTHOR), Mosack, Katie⁶ (AUTHOR), Bhattacharyya, Sanjib⁶ (AUTHOR), Khubbar, Manjeet⁶ (AUTHOR), Yerkes, Nicole R.⁷ (AUTHOR), Campos, Brooke⁷ (AUTHOR), Paegle, Alina⁷ (AUTHOR), McGee, John⁷ (AUTHOR), Herrera, Robert⁷ (AUTHOR), Pearlowitz, Marcia⁸ (AUTHOR), Williams, Thelonious W.⁸ (AUTHOR), Kirking, Hannah L.¹ (AUTHOR)

Source: PLoS ONE. 1/9/2025, Vol. 20 Issue 1, p1-17. 17p.

Subject Terms: *SARS-CoV-2 Omicron variant, *SARS-CoV-2 Delta variant, *SARS-CoV-2, *BIOCOMPLEXITY, *CONTACT tracing

Difference in Optical Coherence Tomography Angiography Parameters After SARS-CoV-2 Infection During the Alpha and Delta Variant Dominance Periods.

Authors: Kal, Magdalena^1,2 (AUTHOR), Brzdęk, Michał^1,3 (AUTHOR) michal.brzdek@gmail.com, Karska-Basta, Izabella^4,5 (AUTHOR), Rzymski, Piotr⁶ (AUTHOR) rzymskipiotr@ump.edu.pl, Pinna, Antonio⁷ (AUTHOR) apinna@uniss.it, Mackiewicz, Jerzy⁸ (AUTHOR), Odrobina, Dominik^2,9 (AUTHOR), Zarębska-Michaluk, Dorota¹⁰ (AUTHOR), Flisiak, Robert¹¹ (AUTHOR) robert.flisiak1@gmail.com

Source: Viruses (1999-4915). Jan2025, Vol. 17 Issue 1, p47. 16p.

Subject Terms: *SARS-CoV-2 Delta variant, *SARS-CoV-2, *COVID-19, *SYMPTOMS, *ANGIOGRAPHY, *OPTICAL coherence tomography

Current Treatment Regimens and Promising Molecular Therapies for Chronic Hepatobiliary Diseases.

Authors: Durazzo, Marilena¹ (AUTHOR) marilena.durazzo@unito.it, Ferro, Arianna¹ (AUTHOR) arianna.ferro@unito.it, Navarro-Tableros, Victor Manuel² (AUTHOR) victor.navarro@2i3t.it, Gaido, Andrea¹ (AUTHOR) andrea.gaido@unito.it, Fornengo, Paolo¹ (AUTHOR) paolo.fornengo@unito.it, Altruda, Fiorella³ (AUTHOR) fiorella.altruda@unito.it, Romagnoli, Renato⁴ (AUTHOR) renato.romagnoli@unito.it, Moestrup, Søren K.^5,6 (AUTHOR) sm@biomed.au.dk, Calvo, Pier Luigi⁷ (AUTHOR) pierluigi.calvo@unito.it, Fagoonee, Sharmila⁸ (AUTHOR) sharmila.fagoonee@unito.it

Source: Biomolecules (2218-273X). Jan2025, Vol. 15 Issue 1, p121. 40p.

Subject Terms: *HEPATIC fibrosis, *SARS-CoV-2 Delta variant, *AUTOIMMUNE hepatitis, *MEDICAL research, *LIVER diseases, *VIRAL hepatitis, *CHOLANGITIS

Mathematical Modelling on Dynamics of Multi-variant SARS-CoV-2 Virus: Estimating Delta and Omicron Variant Impact on COVID-19.

Authors: Gupta, Sadhana¹ paramsadhana13@gmail.com, Rupali² rupali@krmangalam.edu.in, Rajoria, Yogendra Kumar³ yogendrakr.rajoria@krmangalam.edu.in, Sahu, Govind Prasad⁴ govind3012@gmail.com

Source: IAENG International Journal of Applied Mathematics. Jan2025, Vol. 55 Issue 1, p180-188. 9p.

Subject Terms: *SARS-CoV-2 Delta variant, *SARS-CoV-2 Omicron variant, *SARS-CoV-2, *BIRTH rate, *CONTINUOUS time models

TNF-α exacerbates SARS-CoV-2 infection by stimulating CXCL1 production from macrophages.

Authors: Kobayashi, Moe¹ (AUTHOR), Kobayashi, Nene¹ (AUTHOR), Deguchi, Kyoka¹ (AUTHOR), Omori, Seira¹ (AUTHOR), Nagai, Minami¹ (AUTHOR), Fukui, Ryutaro² (AUTHOR), Song, Isaiah³ (AUTHOR), Fukuda, Shinji^3,4,5,6 (AUTHOR), Miyake, Kensuke² (AUTHOR), Ichinohe, Takeshi¹ (AUTHOR) ichinohe@ims.u-tokyo.ac.jp

Source: PLoS Pathogens. 12/9/2024, Vol. 20 Issue 12, p1-22. 22p.

Subject Terms: *SARS-CoV-2 Delta variant, *TYPE I interferons, *VIRUS diseases, *INTERFERON receptors, *SARS-CoV-2, *COVID-19

Cellular sialoglycans are differentially required for endosomal and cell-surface entry of SARS-CoV-2 in lung cell lines.

Authors: Siwak, Kimberley C.¹ (AUTHOR), LeBlanc, Emmanuelle V.¹ (AUTHOR), Scott, Heidi M.¹ (AUTHOR), Kim, Youjin¹ (AUTHOR), Pellizzari-Delano, Isabella¹ (AUTHOR), Ball, Alice M.¹ (AUTHOR), Temperton, Nigel J.² (AUTHOR), Capicciotti, Chantelle J.^1,3,4 (AUTHOR), Colpitts, Che C.¹ (AUTHOR) che.colpitts@queensu.ca

Source: PLoS Pathogens. 12/3/2024, Vol. 20 Issue 12, p1-29. 29p.

Subject Terms: *SARS-CoV-2 Delta variant, *SARS-CoV-2 Omicron variant, *SIALIC acids, *RESPIRATORY infections, *COMMON cold

In silico Molecular Docking Analysis Reveals Successful Protein Ligand Interaction between Druggable Bioactives from Ginger and RNA Dependent RNA Polymerase (EC 2.7.7.48) of SARS-CoV-2 Delta Variant.

Authors: Debnath, Tania¹, Ghosh, Upal Das² upal_das_ghosh@yahoo.com

Source: Journal of Pure & Applied Microbiology. Dec2024, Vol. 18 Issue 4, p2659-2673. 15p.

Subject Terms: *SARS-CoV-2 Delta variant, *RNA polymerases, *PROTEIN-protein interactions, *GINGER, *COVID-19 pandemic, *VIRAL proteins

Geographic Terms: INDIA

Two strains model of infectious diseases for mathematical analysis and simulations.

Authors: Eiman¹ (AUTHOR), Shah, Kamal^1,2 (AUTHOR), Hleili, Manel³ (AUTHOR), Abdeljawad, Thabet^2,4,5 (AUTHOR) tabdeljawad@psu.edu.sa

Source: Mathematical & Computer Modelling of Dynamical Systems. Dec2024, Vol. 30 Issue 1, p477-495. 19p.

Subject Terms: *SARS-CoV-2 Delta variant, *SARS-CoV-2 Omicron variant, *FIXED point theory, *EULER method, *MATHEMATICAL analysis

Persistence of Long COVID Symptoms Two Years After SARS-CoV-2 Infection: A Prospective Longitudinal Cohort Study.

Authors: Joseph, Gili^1,2 (AUTHOR) gili.joseph@sheba.health.gov.il, Margalit, Ili^1,2,3 (AUTHOR) ili.margalit@sheba.health.gov.il, Weiss-Ottolenghi, Yael¹ (AUTHOR) yael.ottolenghi@sheba.health.gov.il, Rubin, Carmit⁴ (AUTHOR) carmitr@gertner.health.gov.il, Murad, Havi⁴ (AUTHOR) havim@gertner.health.gov.il, Gardner, Raquel C.⁵ (AUTHOR), Barda, Noam^1,6,7,8 (AUTHOR) noam.barda@sheba.health.gov.il, Ben-Shachar, Elena^3,9 (AUTHOR) yitshak.kreiss@sheba.health.gov.il, Indenbaum, Victoria¹⁰ (AUTHOR) viki.indenbaum@sheba.health.gov.il, Gilboa, Mayan^1,2,3 (AUTHOR) maayan.gilboa@sheba.health.gov.il, Alroy-Preis, Sharon¹¹ (AUTHOR) sharon.alroy@moh.gov.il, Kreiss, Yitshak^3,9 (AUTHOR), Lustig, Yaniv^3,10 (AUTHOR), Regev-Yochay, Gili^1,2,3 (AUTHOR) gili.regev@sheba.health.gov.il

Source: Viruses (1999-4915). Dec2024, Vol. 16 Issue 12, p1955. 11p.

Subject Terms: *POST-acute COVID-19 syndrome, *SARS-CoV-2 Delta variant, *COVID-19, *LOGISTIC regression analysis, *VACCINATION

Comparative Evolutionary Epidemiology of SARS-CoV-2 Delta and Omicron Variants in Kuwait.

Authors: Alkhamis, Moh A.¹ (AUTHOR) h.abrar@ku.edu.kw, Hussain, Abrar¹ (AUTHOR), Al-Therban, Fayez² (AUTHOR) drfayez@altherban.org

Source: Viruses (1999-4915). Dec2024, Vol. 16 Issue 12, p1872. 17p.

Subject Terms: *SARS-CoV-2 Omicron variant, *SARS-CoV-2 Delta variant, *SARS-CoV-2, *PHYLOGEOGRAPHY, *AGE groups, *DEMOGRAPHIC change

Exploring the Replication and Pathogenic Characteristics of Alpha, Delta, and Omicron Variants of SARS-CoV-2.

Authors: Khan, Sakirul^1,2 (AUTHOR) sakirul@oita-u.ac.jp, Yahiro, Takaaki^1,2,3 (AUTHOR), Kimitsuki, Kazunori^1,2 (AUTHOR), Hashimoto, Takehiro^2,4 (AUTHOR), Matsuura, Keiko⁵ (AUTHOR), Yano, Shinji⁶ (AUTHOR), Noguchi, Kazuko² (AUTHOR), Sonezaki, Akane² (AUTHOR), Yoshizawa, Kaori² (AUTHOR), Kumasako, Yoko¹ (AUTHOR), Akbar, Sheikh Mohammad Fazle^1,7,8 (AUTHOR), Nishizono, Akira^1,2 (AUTHOR) sakirul@oita-u.ac.jp

Source: International Journal of Molecular Sciences. Dec2024, Vol. 25 Issue 23, p12641. 16p.

Subject Terms: *SARS-CoV-2 Omicron variant, *SARS-CoV-2 Delta variant, *COVID-19, *CELL nuclei, *SARS-CoV-2

Remodeling of intracellular architecture during SARS-CoV-2 infection of human endothelium.

Authors: Kubisiak, Agata^1,2 (AUTHOR) agata.kubisiak@doctoral.uj.edu.pl, Dabrowska, Agnieszka³ (AUTHOR) agnieszka.dabrowska@doctoral.uj.edu.pl, Botwina, Pawel³ (AUTHOR), Twardawa, Patrycja^1,2 (AUTHOR), Kloska, Damian^4,5 (AUTHOR), Kołodziej, Tomasz^6,7 (AUTHOR), Rajfur, Zenon⁷ (AUTHOR), Pyrc, Krzysztof³ (AUTHOR), Targosz-Korecka, Marta¹ (AUTHOR)

Source: Scientific Reports. 11/30/2024, Vol. 14 Issue 1, p1-16. 16p.

Subject Terms: *SARS-CoV-2 Delta variant, *ENDOTHELIAL cells, *SARS-CoV-2, *EPITHELIAL cells, *CARDIOLOGICAL manifestations of general diseases

Haplotypic Distribution of SARS-CoV-2 Variants in Cases of Intradomiciliary Infection in the State of Rondônia, Western Amazon.

Authors: Teixeira, Karolaine Santos^1,2,3 (AUTHOR), Custódio, Márlon Grégori Flores¹ (AUTHOR), Sgorlon, Gabriella^1,2,4,5 (AUTHOR), Roca, Tárcio Peixoto^1,2,6 (AUTHOR), Queiroz, Jackson Alves da Silva^1,2,4,5 (AUTHOR), Passos-Silva, Ana Maisa^1,2,4 (AUTHOR), Ribeiro, Jessiane^1,2 (AUTHOR), Vieira, Deusilene^1,2,4,5 (AUTHOR) deusilene.vieira@fiocruz.br

Source: Bioinformatics & Biology Insights. 11/21/2024, p1-8. 8p.

Subject Terms: *SARS-CoV-2, *SARS-CoV-2 Delta variant, *SARS-CoV-2 Omicron variant, *COVID-19 pandemic, *VIRAL genomes